
This symposium will present a diverse series of lectures on advances and innovations in clinical pharmacology designs, methodology, and theory. This session will present the latest cutting edge methods being done by industry and academia and will discuss the future of clinical pharmacology, particularly early drug development.
Peter L. Bonate, Ph.D., F.C.P.
Genzyme Corporation
Daniel Salazar
Sankyo Pharma Development
2:00 pm
Theranostics: Real-time PD/PK Monitoring
Elizabeth Holmes, Ph.D.
Theranos, Inc.
2:30 pm
Adaptive Dose-ranging Studies for Effiecient and Accurate Dose Selection
Jose Pinheiro
Novartis Pharmaceutical
Jeff Maca
Novartis Pharmaceutical
3:00 pm
Transcriptonal Biomarkers n Early Clinical Development: The Importance of Baseline Variation
Karen Brown, Ph.D.
Daiichi Sankyo Pharma Development
3:30 pm
Regulatory Perspective on Pharmacogenetics of Warfarin and Relabeling
Myong-Jin Kim, Ph.D.
U.S. Food and Drug Administration
4:00 pm
Panel Discussion
Back to Top
Contact Us | Feedback
© 2007 American Association of Pharmaceutical Scientists www.aapspharmaceutica.com